Clinical Trial Update: Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating Se-Methyl-Seleno-L-Cysteine or Selenomethionine for preventing prostate cancer in healthy participants; the study spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Se-Methyl-Seleno-L-Cysteine (Se-Methyl-Seleno-L-Cysteine)
• Selenomethionine (selenomethionine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: No Evidence of Disease, Prostate Carcinoma | Phase 1 | Status: COMPLETED